Trehan N, Mishra M, Bapna R, Mishra A, Maheshwari P, Karlekar A
Escorts Heart Institute and Research Centre, New Delhi, India.
Eur J Cardiothorac Surg. 1997 Aug;12(2):276-84. doi: 10.1016/s1010-7940(97)00098-5.
To achieve complete myocardial revascularisation in patients with diffuse coronary artery disease, patients with inordinately high risk of cardiopulmonary bypass (CPB) like severe systemic disease or diffuse atherosclerosis of the aorta.
We have adopted the technique of combining coronary artery bypass grafting (CABG) with transmyocardial laser revascularisation (TMLR) using 1000 W CO2 laser machine. TMLR is done to areas supplied by ungraftable arteries, while CABG without cardiopulmonary bypass is done to the left anterior descending artery (LAD) and/or right coronary artery (RCA). TMLR + CABG on beating heart without CPB has been performed on 56 patients. Age ranged from 37 to 81 years with a mean of 56.17. Four patients were in renal failure, two were redo CABG. Preoperatively 39.28% patients had angina class III and 10.71% had angina class IV. Four patients were on preoperative IABP support.
The mean number of grafts was 1.09. Internal thoracic artery (ITA) was used in 96.4% of the patients. Five patients showed elevation of CPK-MB, while three patients had an increase in Troponin T. Mortality was 1.8% (one patient died of intractable ventricular arrhythmia). The mean follow-up is 9.2 months. Myocardial perfusion scanning showed a stepwise improvement in reversible ischemia increasing from 52% at baseline to 91% at 12 months; 90.9% of the patients were angina free at 12 months. Metabolic stress test demonstrated an average increase in exercise tolerance from 5.2 min at baseline to 9.4 min at 12 months. Metabolic equivalents (METs) increased from 4.5 at baseline to 9.4 at 12 months. The average 44% Karnofsky score preoperative also increased to 86% at 12 months.
Our results indicate that the technique is surgically feasible and safe, with excellent short term results.
在弥漫性冠状动脉疾病患者、存在如严重全身性疾病或主动脉弥漫性动脉粥样硬化等体外循环(CPB)极高风险的患者中实现完全心肌血运重建。
我们采用了使用1000W二氧化碳激光机将冠状动脉旁路移植术(CABG)与经心肌激光血运重建术(TMLR)相结合的技术。TMLR应用于不可移植动脉供血的区域,而在非体外循环下对左前降支动脉(LAD)和/或右冠状动脉(RCA)进行CABG。已对56例患者在非体外循环下的跳动心脏上进行了TMLR + CABG。年龄范围为37至81岁,平均年龄为56.17岁。4例患者处于肾衰竭状态,2例为再次行CABG。术前39.28%的患者为Ⅲ级心绞痛,10.71%为Ⅳ级心绞痛。4例患者术前接受主动脉内球囊反搏(IABP)支持。
平均移植血管数量为1.09。96.4%的患者使用了胸廓内动脉(ITA)。5例患者肌酸磷酸激酶同工酶(CPK-MB)升高,3例患者肌钙蛋白T升高。死亡率为1.8%(1例患者死于顽固性室性心律失常)。平均随访时间为9.2个月。心肌灌注扫描显示可逆性缺血呈逐步改善,从基线时的52%增加至12个月时的91%;90.9%的患者在12个月时无心绞痛。代谢应激试验表明运动耐量平均从基线时的5.2分钟增加至12个月时的9.4分钟。代谢当量(METs)从基线时的4.5增加至12个月时的9.4。术前平均44%的卡诺夫斯基评分在12个月时也升至86%。
我们的结果表明该技术在手术上是可行且安全的,具有出色的短期效果。